Search Results
Mar 12, 2026, 14:42 ET Micro Electrode Array Market to Reach USD 1,991.35 Million by 2032 Amid Rising Neuroscience Research, iPSC-Based Disease Modeling, and High-Density Electrophysiology Adoption - Credence Research
PlayersAxion BioSystems, Inc.; Multi Channel Systems MCS GmbH; 3Brain AG;NeuroNexus Technologies, Inc.; Blackrock Neurotech; MaxWell Biosystems }AG; Microprobes for Life Science; MicruX Technologies;
More news about: Credence Research Inc.
Feb 26, 2026, 07:00 ET Graphite One Announces Appointment of Lucille Carter as Vice President, Community Relations and Online Marketing Update
party and MCS has agreed to comply with applicable securities laws and the policies of the TSX venture Exchange in providing its services.The Company will not issue any securities to i2i or MCS as compensation for their services. As at the date hereof, to the Company's knowledge, i2i and MCS does not
More news about: Graphite One Inc.
Feb 19, 2026, 09:31 ET CPSC Posts Product Recalls to its Web Site
Meijer Recalls Lullaby Lane and MCS Children's Sleepwear Due to Burn Hazard; Violates Mandatory Standard for Children's Sleepwear
More news about: U.S. Consumer Product Safety Commission
Feb 18, 2026, 07:30 ET First Patients Dosed in Alphyn Biologics' Phase 2 Trial of First-in-Class Topical Therapeutic for Molluscum Contagiosum
disease – including, uniquely, the direct elimination of the virus itself with a skin-friendly, well-tolerated topical formulation – plus targeting MC's itch, inflammation and, in certain patients, dermatitis and bacterial infection with its associated pain."The randomized, double-blind, placebo-controlled
More news about: Alphyn Biologics, Inc.
Feb 12, 2026, 19:00 ET 健永生技公司報告臨床驗證和商業化嘗試轉型期成果：二期臨床試驗數據聚焦於MCS-8 在腫瘤預防和代謝健康領域雙重治療潛力，同時公司策略進軍亞洲市場
-- 健永生技股份有限公司（納斯達克股票代碼：MENS）（以下簡稱「本公司」或「健永生技」）今日發布了一項企業策略更新報告。這份回顧報告總結了一個關鍵時期，其中包括其主要候選藥物 MCS-8 的二期臨床試驗順利完成，同時該公司也積極嘗試在亞洲主要市場進行商業推廣。公司認為，腫瘤學方面的正面結果與意外的代謝益處的結合有可能降低了其產品線的風險，並使健永生技在前列腺癌的預防醫學領域處於前沿位置。 釋放 MCS-8 的「雙重作用」潛能：腫瘤預防醫學與代謝健康的結合該公司近期在完成其針對 MCS-8 的第二階段隨機、安慰劑對照試驗後，取得了重要的階段性成果。該試驗在台灣的 20 家醫療中心共招募了超過 700 名攝護腺癌高風險患者。根據先前的揭露，該研究的主要療效分析顯示，與安慰劑組相比，MCS-8
More news about: 健永生技股份有限公司
Feb 12, 2026, 05:55 ET SALAMA Reports strong improvement in Full-Year 2025 Results With Reinforced Capital Position
optimisation, and prudent investment allocation, alongside completing a capital reduction and initiating the issuance of a Mandatory Convertible Sukuk (MCS) for a maximum amount up to AED 155 million to enhance solvency and support sustainable growth.The Board-approved transformation plan has further
More news about: Islamic Arab Insurance Co. (Salama)
Feb 12, 2026, 05:50 ET SALAMA Reports strong improvement in Full-Year 2025 Results With Reinforced Capital Position
optimisation, and prudent investment allocation, alongside completing a capital reduction and initiating the issuance of a Mandatory Convertible Sukuk (MCS) for a maximum amount up to AED 155 million to enhance solvency and support sustainable growth.The Board-approved transformation plan has further
More news about: Islamic Arab Insurance Co. (Salama)
Jan 12, 2026, 09:00 ET Curtin Maritime Selects Motive Energy to Deliver Large-Scale Solar & BESS Charging Infrastructure for Electric Tugboats at the Port of Los Angeles
Charging operations will be supported by four 1-megawatt high-capacity charging systems (MCS) designed specifically to support the demanding duty cycles, fast-turnaround needs, and multiport charging requirements of electric tugboat operations.
More news about: Motive Energy
Jan 07, 2026, 09:00 ET CSA Medical Submits PMA for RejuvenAir® System Following Positive Results from Pivotal SPRAY-CB Trial
results from SPRAY-CB, a multicenter, randomized, sham-controlled pivotal clinical trial evaluating the safety and effectiveness of Metered CryoSpray (MCS) therapy delivered bronchoscopically using the RejuvenAir System. The study met its primary endpoint and multiple secondary endpoints with statistical
More news about: CSA Medical
Dec 03, 2025, 17:00 ET Northeast Delta Human Services Authority and Monroe City Schools Partner to Promote Student Wellness and Prevention Programs
La., Dec. 3, 2025 /PRNewswire/ -- Northeast Delta Human Services Authority (NEDHSA) and Monroe City Schools (MCS) have entered into a Memorandum of Understanding (MOU) to promote and provide prevention and wellness services for students and staff across the district.
More news about: Northeast Delta Human Services Authority
Nov 14, 2025, 09:00 ET Make This Holiday Hands-On: DOVAMAN Black Friday Deals Up to 36% Off
https://www.amazon.com/TITANCE-X9-Brushless-Heavy-Duty-Industrial/dp/B0DY1R963Z The MCS01A Circular Saw is designed for DIYers who want precise, versatile cuts on wood, metal, PVC, and tile. Featuring six interchangeable blades, it is compact
More news about: DOVAMAN
Nov 11, 2025, 09:11 ET Full Sail University to Host EA SPORTS™ College Football 26 Live Championship Broadcast of the Army-Navy Game Tournament presented by USAA
Sports and Full Sail University announced the return of the Madden NFL 26 Championship Series (MCS 26) to the Full Sail University Orlando Health Fortress for the second consecutive year with four select MCS 26 competitions and broadcast productions spanning dates from September 2025 through January 2026.
More news about: Full Sail University
Nov 08, 2025, 10:40 ET Clinically meaningful pivotal study results for olezarsen in sHTG presented as a late breaker at AHA Scientific Sessions
≥880 mg/dL, which is often equated to multifactorial chylomicronemia syndrome (MCS) due to the associated increased accumulation of chylomicrons. The effect on triglyceride-lowering and reduction in acute pancreatitis in the MCS subgroup were in line with the overall population. These
More news about: Swedish Orphan Biovitrum AB
Nov 07, 2025, 11:44 ET MCS Announces Agreement to Sell Mortgage Services Business Line to Stewart
Upon completion of the sale, MCS will continue to operate the MCS Commercial, MCS Residential, and MCS Government Services businesses, along with the associated sub brands of each of those entities. As part of the agreement, Stewart will acquire all MCS operations, processes, and technology
More news about: MCS
Nov 07, 2025, 08:52 ET Weltweit erste, auf APOC3 abzielende Gen-Editing-Therapie zur Behandlung von Hyperlipidämie
schweren Hypertriglyceridämie (sHTG), zu der das familiäre Chylomikronämie-Syndrom (FCS) und das multifaktorielle Chylomikronämie-Syndrom (MCS) gehören. FCS ist eine seltene autosomal-rezessive Erkrankung, die durch biallelische Mutationen im Lipoproteinlipase (LPL)-Gen oder anderen
More news about: CorrectSequence Therapeutics
Nov 07, 2025, 08:24 ET La primera terapia de edición genética del mundo dirigida a APOC3 para la hiperlipidemia
lipoproteína lipasa (LPL) u otros genes reguladores clave, con TG en ayunas ≥10 mmol/L (885 mg/dL) y una prevalencia global de 1 en 100.000 a 1.000.000. MCS es el resultado de una interacción compleja de trastornos genéticos, de estilo de vida o metabólicos con una prevalencia de hasta 1 entre 600 en todo
More news about: CorrectSequence Therapeutics
Nov 05, 2025, 19:42 ET The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
Chylomicronemia Syndrome (MCS). FCS is a rare autosomal recessive disorder caused by biallelic mutations in the Lipoprotein Lipase (LPL) gene or other key regulatory genes, with fasting TG ≥10 mmol/L (885 mg/dL) and a global prevalence of 1 in 100,000–1,000,000. MCS results from a complex
More news about: CorrectSequence Therapeutics
Nov 05, 2025, 19:00 ET The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
Chylomicronemia Syndrome (MCS). FCS is a rare autosomal recessive disorder caused by biallelic mutations in the Lipoprotein Lipase (LPL) gene or other key regulatory genes, with fasting TG ≥10 mmol/L (885 mg/dL) and a global prevalence of 1 in 100,000–1,000,000. MCS results from a complex
More news about: CorrectSequence Therapeutics
Oct 24, 2025, 17:49 ET Meijer retira de forma voluntaria del mercado determinadas prendas de dormir infantiles de temporada de las marcas Lullaby Lane y Meijer
anuncia el retiro voluntario del mercado de determinadas prendas de ropa de dormir para niños de las marcas Lullaby Lane y Meijer Corporate Seasonal (MCS), ya que estas prendas no se sometieron a todas las pruebas necesarias para comprobar que cumplen las normas de inflamabilidad correspondientes a su
More news about: Meijer
Oct 23, 2025, 14:28 ET Meijer Voluntarily Recalls Select Lullaby Lane and Meijer Seasonal Children's Sleepwear
Oct. 23, 2025 /PRNewswire/ -- Meijer is announcing a voluntary recall of select Lullaby Lane and Meijer Corporate Seasonal (MCS) branded children's sleepwear because the garments were not fully tested against the correct size flammability standards. These products are being recalled
More news about: Meijer
Oct 19, 2025, 16:01 ET Sobi announces revised full year outlook and advances publication of the Q3 2025 financial report
by multifactorial chylomicronemia syndroms (MCS), a subgroup of sHTG patients. Given the significant number of cases, Sobi believes this condition could offer a market potential exceeding SEK 5 billion within these countries. Sobi plans regulatory filing in MCS in Europe in 2026. Sobi holds the commercial
More news about: Swedish Orphan Biovitrum AB
Oct 19, 2025, 15:59 ET Sobi announces revised full year outlook and advances publication of the Q3 2025 financial report
by multifactorial chylomicronemia syndroms (MCS), a subgroup of sHTG patients. Given the significant number of cases, Sobi believes this condition could offer a market potential exceeding SEK 5 billion within these countries. Sobi plans regulatory filing in MCS in Europe in 2026. Sobi holds the commercial
More news about: Swedish Orphan Biovitrum AB
Oct 19, 2025, 10:30 ET Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer
6 Zhang L, Chai AWY, Wong MCS, et al. Incidence and survival outcomes of human papillomavirus–associated head and neck cancers: A population-based study. JAMA Netw Open. 2024;7(7):e2421771.
More news about: Johnson & Johnson
Oct 17, 2025, 10:18 ET Sungrow Unveils ChargeStack 1000 -- A 3.5 MW Megawatt Charging System in Europe
operators can scale effortlessly from 1 MW to 3.5 MW. The system supports MCS (1500A) and CCS2: 500 A oil-cooled (boost 800A) standards, enabling one solution to serve diverse fleet applications. Its decoupled architecture allows MCS or V2G upgrades without hardware replacement, reducing upgrade costs by
More news about: Sungrow Power Supply Co., Ltd.
Oct 17, 2025, 05:00 ET Salama Shareholders Approve Landmark Capital Restructuring to Strengthen Solvency and Regulatory Capital Position
and subject to final regulatory approvals, Salama will issue, through a special purpose vehicle, up to AED 175 million in Mandatory Convertible Sukuk (MCS) to a select group of strategic investors with confirmed participation interest The recapitalisation will reinforce Salama's
More news about: Islamic Arab Insurance Co. (Salama)